2-[(2S)-1-(3-Ethyl-7-{[(1-oxido-3-pyridinyl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)-2-piperidinyl]ethanol(CAS: 779353-01-4)

This compound (CAS: 779353-01-4) must comply with GHS classification for hazardous materials, REACH regulations for classification and labeling, as well as FDA and EPA requirements for use in the United States. Specific handling, storage, and disposal guidelines must be adhered to based on its potential hazards and intended use.

Several alternatives exist, including analogous compounds such as 2-[(2S)-1-(3-isopropyl-7-{[(1-oxido-3-pyridinyl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)-2-piperidinyl]ethanol and other isomers. Common reagents and synthetic routes can also be explored, such as using different amino acids or modifying the pyrazolo[1,5-a]pyrimidin-5-yl moiety.

Research and development trends for this compound (CAS: 779353-01-4) are focused on its potential applications in medicinal chemistry, particularly in drug discovery for treating diseases such as cancer and neurological disorders. Market demand is growing as more studies highlight its therapeutic potential.

Waste containing this compound (CAS: 779353-01-4) should be collected in appropriate containers and disposed of through professional waste disposal services that adhere to local and international regulations. Environmental protection precautions, such as neutralizing any acidic or basic components, should be taken to prevent environmental contamination. Incineration is a common method for disposal, but it must comply with strict environmental and safety standards.